Elahere

FDA grants full approval to AbbVie's ovarian cancer therapy
Reuters
Sun, 03/24/24 - 10:25 pm
AbbVie
ovarian cancer
Elahere
AbbVie pays $10B to acquire ImmunoGen, doubling down on red-hot ADC cancer field
Fierce Pharma
Thu, 11/30/23 - 10:20 am
AbbVie
M&A
antibody-drug conjugate
Immunogen
Elahere
ovarian cancer
Lilly links up European ADC network, snagging Elahere rival in latest biotech buy
Fierce Biotech
Thu, 10/19/23 - 10:10 am
Eli Lilly
M&A
antibody-drug conjugate
Elahere
Mablink
ImmunoGen’s drug Elahere offers hope for ovarian cancer patients
Clinical Trials Arena
Wed, 05/17/23 - 10:50 pm
Immunogen
Elahere
clinical trials
platinum-resistant ovarian cancer
ovarian cancer
ImmunoGen reports positive top-line data from ovarian cancer therapy trial
Clinical Trials Arena
Thu, 05/4/23 - 09:17 am
Immunogen
clinical trial
ovarian cancer
platinum-resistant ovarian cancer
Elahere